Abstract:In healthy individuals, the healing of soft tissues such as skin after pathological insult or post injury follows a relatively predictable and defined series of cell and molecular processes to restore tissue architecture and function(s). Healing progresses through the phases of hemostasis, inflammation, proliferation, remodeling, and concomitant with re-epithelialization restores barrier function. Soft tissue healing is achieved through the spatiotemporal interplay of multiple different cell types including neutrophils, monocytes/macrophages, fibroblasts, endothelial cells/pericytes, and keratinocytes. Expressed in most cell types, c-Jun N-terminal kinases (JNK) are signaling molecules associated with the regulation of several cellular processes involved in soft tissue wound healing and in response to cellular stress. A member of the mitogen-activated protein kinase family (MAPK), JNKs have been implicated in the regulation of inflammatory cell phenotype, as well as fibroblast, stem/progenitor cell, and epithelial cell biology. In this review, we discuss our understanding of JNKs in the regulation of cell behaviors related to tissue injury, pathology, and wound healing of soft tissues. Using models as diverse as Drosophila, mice, rats, as well as human tissues, research is now defining important, but sometimes conflicting roles for JNKs in the regulation of multiple molecular processes in multiple different cell types central to wound healing processes. In this review, we focus specifically on the role of JNKs in the regulation of cell behavior in the healing of skin, cornea, tendon, gingiva, and dental pulp tissues. We conclude that while parallels can be drawn between some JNK activities and the control of cell behavior in healing, the roles of JNK can also be very specific modes of action depending on the tissue and the phase of healing.

JNK Signaling Pathway Involvement in Spinal Cord Neuron Development and Death

JNK signaling and its impact on neural cell maturation and differentiation

JNK Phosphorylation Promotes Natural Degeneration of Cervical Endplate Chondrocytes by Down-Regulating Expression of ANK.

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease

Delayed Inhibition Of C-Jun N-Terminal Kinase Worsens Outcomes After Focal Cerebral Ischemia

Regulation of the JNK Signaling Pathway by Dual Leucine Zipper Kinase DLK

c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo

Hypothesis: JNK Signaling is a Therapeutic Target of Neurodegenerative Diseases

MAPK/JNK signaling: A potential autophagy regulation pathway.

MAPK/JNK Signalling: a Potential Autophagy Regulation Pathway

JNK Signaling as a Key Modulator of Soft Connective Tissue Physiology, Pathology, and Healing

JNK1 Phosphorylation of SCG10 Determines Microtubule Dynamics and Axodendritic Length

Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment

The Role of the Dysregulated JNK Signaling Pathway in the Pathogenesis of Human Diseases and Its Potential Therapeutic Strategies: A Comprehensive Review

Neuroprotection Against Focal Ischemic Brain Injury by Inhibition of C-Jun N-terminal Kinase and Attenuation of the Mitochondrial Apoptosis-Signaling Pathway.

JNK signaling in apoptosis

Unraveling the Design and Discovery of C-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases.

JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species

Recent Advances in C-Jun N-Terminal Kinase (JNK) Inhibitors

Evidence of Presynaptic Localization and Function of the c-Jun N-Terminal Kinase